Gruell, Henning http://orcid.org/0000-0002-0725-7138
Vanshylla, Kanika http://orcid.org/0000-0003-4552-9170
Tober-Lau, Pinkus http://orcid.org/0000-0002-9148-3663
Hillus, David http://orcid.org/0000-0002-3138-9050
Schommers, Philipp
Lehmann, Clara
Kurth, Florian http://orcid.org/0000-0002-3807-473X
Sander, Leif E. http://orcid.org/0000-0002-0476-9947
Klein, Florian http://orcid.org/0000-0003-1376-1792
Funding for this research was provided by:
Deutsches Zentrum für Infektionsforschung
Deutsche Forschungsgemeinschaft (CRC1310)
Bundesministerium für Bildung und Forschung (01KX2021, 01KX2021)
Bundesinstitut für Arzneimittel und Medizinprodukte (Federal Institute for Drugs and Medical Devices)
Article History
Received: 13 December 2021
Accepted: 22 December 2021
First Online: 19 January 2022
Competing interests
: H.G., K.V. and F. Klein are listed as inventors on pending patent application(s) on SARS-CoV-2-neutralizing antibodies filed by the University of Cologne. All other authors have no competing interests.